docetaxelTJ-M2010-5metastatic NSCLCplatinum therapy
…d FDA approval for concurrent use with PD-1/PD-L1 inhibitors or docetaxel in metastatic NSCLC progressing after platinum therapy. The cur…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: TJ-M2010-5 ×
TJ-M2010-5
This drug is selected. Its supporting articles are shown below.